Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020198166 - MATERIALS AND METHODS FOR TREATING POLYCYSTIC KIDNEY DISEASE

Publication Number WO/2020/198166
Publication Date 01.10.2020
International Application No. PCT/US2020/024310
International Filing Date 23.03.2020
IPC
A61K 39/395 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
A61P 13/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
13Drugs for disorders of the urinary system
A61P 13/12 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
13Drugs for disorders of the urinary system
12of the kidneys
C12N 15/15 2006.01
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
15Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
09Recombinant DNA-technology
11DNA or RNA fragments; Modified forms thereof
12Genes encoding animal proteins
15Protease inhibitors, e.g. antithrombin, antitrypsin, hirudin
Applicants
  • MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH [US]/[US]
Inventors
  • CHINI, Eduardo N.
Agents
  • FINN, J. Patrick III
Priority Data
62/822,60222.03.2019US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) MATERIALS AND METHODS FOR TREATING POLYCYSTIC KIDNEY DISEASE
(FR) MATÉRIAUX ET PROCÉDÉS DE TRAITEMENT D'UNE POLYKYSTOSE RÉNALE
Abstract
(EN)
Materials and methods for treating polycystic kidney disease (e.g., autosomal dominant polycystic kidney disease (ADPKD)) are provided herein that include using one or more inhibitors of pregnancy associated plasma protein A (PAPP-A) polypeptide expression or activity.
(FR)
L'invention concerne des matériaux et des méthodes de traitement de la polykystose rénale (par exemple, la polykystose rénale autosomique dominante (ADPKD) qui comprennent l'utilisation d'un ou de plusieurs inhibiteurs de l'expression ou de l'activité du polypeptide de la protéine plasmatique A associée à la grossesse (PAPP-A).
Latest bibliographic data on file with the International Bureau